scorecardresearch
Follow Us:
Thursday, August 11, 2022

Novel blood test may help you measure your heart health

After adjustment for known clinical characteristics and risk factors, the study found that the patients with the longest clot lysis time had a 40 per cent increased risk of recurrent myocardial infarction or death due to cardiovascular disease.

By: IANS | London |
February 8, 2018 10:31:05 pm
Blood test, novel blood test, different types of blood tests, blood diseases, Indian express, Indian express news The results of this study showed novel therapies targeting fibrin clot lysis time may improve prognosis in patients with acute coronary syndrome. (Source: File Photo)

Researchers have found a new blood test that could provide a clue as to why some patients are at a higher risk of cardiovascular disease risk after suffering a heart attack.

The results showed novel therapies targeting fibrin clot lysis time may improve prognosis in patients with acute coronary syndrome.

“Our findings provide exciting clues as to why some patients are at higher risk after heart attack and how we might address this with new treatments in the future,” said co-author of the study Rob Storey, professor from the University of Sheffield, UK.

For the study, published in European Heart Journal, researchers analysed blood plasma samples from more than 4,300 patients with acute coronary syndrome as they were discharged from hospital.

Subscriber Only Stories
Why Nitish Kumar felt the absence of Sushil Modi, ‘Jaitley channel’Premium
RSS shake-up for BJP: Why and where allPremium
Indian Monsoon 2022 Live Updates: 2 dead as heavy rains lash Himachal; 3 ...Premium
Delhi Confidential: Shashi Tharoor to receive Legion Of Honour, France&#8...Premium

They measured the maximum density of a clot and the time it took for the clot to break down — known as clot lysis time.

After adjustment for known clinical characteristics and risk factors, the study found that the patients with the longest clot lysis time had a 40 per cent increased risk of recurrent myocardial infarction or death due to cardiovascular disease.

According to the researchers, this research may help them to identify new targets for reducing the risk and eventually lead to more effective treatments.

Advertisement

“We now need to press ahead with exploring possibilities for tailoring treatment to an individual’s risk following a heart attack and testing whether drugs that improve clot lysis time can reduce this risk,” Storey added.

📣 The above article is for information purposes only and is not intended to be a substitute for professional medical advice. Always seek the guidance of your doctor or other qualified health professional for any questions you may have regarding your health or a medical condition.

For all the latest Lifestyle News, download Indian Express App.

  • Newsguard
  • The Indian Express website has been rated GREEN for its credibility and trustworthiness by Newsguard, a global service that rates news sources for their journalistic standards.
  • Newsguard
First published on: 08-02-2018 at 10:31:05 pm

Featured Stories

Advertisement
Advertisement
Advertisement
Advertisement